Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use (MEASURE-ILD)

Development of an Intelligent Video Laryngoscope and Preliminary Verification for Emergency Application

The investigators are developing a video laryngoscope equipped with artificial intelligence technology to enable automatic identification of key airway anatomical structures and real-time guidance during intubation, with the aim of improving the success rate and efficiency of endotracheal intubation in emergency settings.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

120

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Zhejiang
      • Hangzhou, Zhejiang, Kina
        • Rekruttering
        • Second Affiliated Hospital, Zhejiang University, School of Medicine
        • Ta kontakt med:
      • Shaoxing, Zhejiang, Kina, 312000

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patient inclusion criteria: Adult patients in critical condition requiring endotracheal intubation via laryngoscopy (age ≥ 18 years).

Exclusion Criteria:

  • pregnant women, prisoners, recent history of airway surgery, oral or pharyngeal malformations, inability to perform randomization due to the need for emergency endotracheal intubation, or when the investigator deemed it necessary or contraindicated to use AIVL, VL, or DL during the first intubation attempt.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Video Laryngoscope(VL)

Participants randomized to this arm (n=60) will undergo the first endotracheal intubation attempt using a conventional video laryngoscope (VL), without AI-assisted anatomical identification or intubation guidance.

A conventional video laryngoscope will be used for the first endotracheal intubation attempt. The device displays the airway image without AI-assisted identification of anatomical structures or real-time AI intubation guidance.

Eksperimentell: AI-assisted Video Laryngoscope (AIVL)

Participants randomized to this arm (n=60) will undergo the first endotracheal intubation attempt using an AI-assisted video laryngoscope (AIVL), which provides real-time identification of airway anatomical structures and intubation guidance. Operators will receive standardized training on the device controls, guidance interface, and image display before use. Operators may decide whether to follow the AI guidance.

When using the AIVL for the first attempt at laryngoscopy intubation, the operator shall receive pre-procedural training, which primarily covers the functional buttons, the prompt interface, and image display.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
First-pass intubation success rate
Tidsramme: The time from enrollment to completion of intubation (usually within 10 minutes).

Proportion of participants with successful endotracheal tube placement on the first laryngoscopic attempt, confirmed by end-tidal carbon dioxide monitoring.

The time from enrollment to completion of intubation (usually within 10 minutes).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Intubation time
Tidsramme: The time from enrollment to completion of intubation (usually within 10 minutes).

Time in seconds from insertion of the laryngoscope into the oral cavity until the endotracheal tube passes through the glottis.

The time from enrollment to completion of intubation (usually within 10 minutes).
Severe complications occurring within 2 minutes after intubation were defined as severe hypoxemia (peripheral SpO₂ <80%), severe hypotension (systolic blood pressure <65 mmHg), initiation of vasoactive agents, cardiac arrest, or death.
Tidsramme: From enrollment to the 2 minutes after intubation
From enrollment to the 2 minutes after intubation
AI recall
Tidsramme: The time from enrollment to completion of intubation (usually within 10 minutes).

True-positive anatomical detections divided by true-positive plus false-negative detections, assessed against reference annotations.

The time from enrollment to completion of intubation (usually within 10 minutes).
Duration of mechanical ventilation
Tidsramme: From enrollment to the end of treatment at 8 weeks

Duration of mechanical ventilation, measured in days.

From enrollment to the end of treatment at 8 weeks
28-day all-cause mortality
Tidsramme: From enrollment through day 28.

Proportion of participants who die from any cause within 28 days after enrollment.

From enrollment through day 28.
ICU length of stay
Tidsramme: From enrollment through the end of treatment, up to 8 weeks.

Duration of intensive care unit stay, measured in days.

From enrollment through the end of treatment, up to 8 weeks.
Total hospital length of stay
Tidsramme: From enrollment through the end of treatment, up to 8 weeks.

Total duration of hospitalization, measured in days.

From enrollment through the end of treatment, up to 8 weeks.
AI precision
Tidsramme: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

True-positive anatomical detections divided by true-positive plus false-positive detections, assessed against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
AI specificity
Tidsramme: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

True-negative assessments divided by true-negative plus false-positive assessments, assessed against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
AI F1 score
Tidsramme: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Harmonic mean of precision and recall: 2 x precision x recall / (precision + recall).

Video acquired from enrollment to completion of intubation, usually within 10 minutes.
Mean average precision (mAP)
Tidsramme: Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Mean of average precision across the evaluated anatomical classes against reference annotations.

Video acquired from enrollment to completion of intubation, usually within 10 minutes.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

31. desember 2027

Studiet fullført (Antatt)

31. desember 2027

Datoer for studieregistrering

Først innsendt

22. oktober 2026

Først innsendt som oppfylte QC-kriteriene

1. november 2026

Først lagt ut (Faktiske)

6. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere